- Life Science
- AI & Technology
- Clinics and Hospitals
- VC/PE Investment
Guided by our team of biopharmaceutical experts, we support clients across the entire biopharma value chain, from R&D, medical affairs to commercialization.
Our mission is to unlock innovation and accelerate the delivery of new medicines to patients.
We offer data and analytics strategies and solutions to address your most critical questions. Whether it’s identifying real-world patient data for your study, navigating the complex regulatory landscape for real-world evidence, or distinguishing between the practical applications and hype of AI technologies, we’re your trusted guide.
Recognizing the paramount importance of data integrity, we provide only trustworthy, high-quality data sourced from our strategic partners across the United States. Our unwavering commitment is to empower your decision-making process with accurate, timely, and actionable insights.
We offer strategic consulting services to AI and technology companies looking to penetrate the biopharmaceutical market.
We understand the unique challenges and opportunities in this sector and can guide you through the complexities of market entry.
Our team can help identify key stakeholders in potential deals, including decision-makers, champions, influencers, end-users, blockers, executive sponsors, legal & compliance officers, and budget holders.
We leverage our deep industry knowledge and network to help you navigate the landscape, build relationships, and secure deals. With us as your partner, you can confidently make your mark in the life science market.
We extend our consulting expertise to clinics and hospitals, helping them unlock the potential of their data assets.
If you’re wondering how to monetize your data, we can provide strategic guidance and practical solutions tailored to your specific needs.
We also demystify the realm of AI and NLP technologies for you. We separate the hype from reality and highlight the tangible benefits these technologies can bring to your operations. Our goal is to help you leverage these advanced tools to improve patient care, streamline processes, and ultimately, enhance your bottom line.
We cater to the needs of VC/PE and other investment firms by offering comprehensive due diligence checks.
Our team is adept at providing landscape overviews and market assessments for new technologies in the health sector. We can help you evaluate specific target companies for M&A and investment considerations. Our in-depth analyses and insights can guide your investment decisions, helping you identify promising opportunities and mitigate risks.
With our support, you can navigate the investment landscape with confidence and precision.
Case Studies
Client: A key player in the women’s health sector sought our expertise for a real-world database study project to identify new niche market for an established product among specific woman populations.
Challenge: The primary challenge was to understand the unique market dynamics of the Asia Pacific region in the context of women’s health and collaborate with multiple stakeholders from the client’s organization.
Solution: The project was executed over a period of 6 months and involved several key stages:
- We conducted extensive research to understand the market and the unique challenges and opportunities it presents.
- We assessed the viability of the project, taking into account various factors such as clinical practice, data availability and quality.
- We developed robust statistical methods tailored to the specific needs of the project.
- We carried out the analysis, ensuring accuracy and reliability in our findings.
Outcomes: The project resulted in the publication of 4 abstracts in leading women’s health conferences, with more currently in preparation. Our findings also guided the client to new niche marketing areas for their unique product, opening up new opportunities for growth and expansion.
Testimonial: “I am extremely pleased with the exceptional work delivered by your team! Your profound comprehension of the women’s health market, the development of robust statistical methods, and the precise analysis conducted helped me publish 4 abstracts promptly.” by Hiroshi, Director in HEOR
Client: A leading vaccine manufacturer aimed to promptly and automatically monitor global infectious disease outbreaks, preparing their manufacturing, distribution, sales, and medical affairs teams for swift response.
Challenge: The task was complex due to the scattered information in multilingual news reports, which required dedicated teams for tracking – a process that was both time-consuming and costly.
Solution: We applied cutting-edge Large Language Models (LLMs) to extract information about infectious disease outbreaks. Our approach involved:
- Systematic testing of multiple LLMs with varying parameter settings and prompts to ensure accuracy and consistency.
- Selection of the optimal LLM with the most suitable parameter setting.
- Construction of an automated Python workflow to periodically scan news reports, extract outbreak information, and store it in a relational database.
- Development of a real-time visualization dashboard to present the results.
Outcomes: Our AI-powered workflow offered an efficient solution for infectious disease outbreak surveillance. This enabled the client to make informed decisions based on timely and accurate information. The system utilized the most advanced AI model to accurately extract structured information from unstructured text, demonstrating potential for extension to numerous other use cases.
Testimonial: “Your innovative approach, particularly the use of cutting-edge Large Language Models, was truly impressive. The prompt delivery and ease of collaboration made the project a success. Your team’s dedication to delivering high-quality work is commendable.” by Jennette, Director in Marketing
Our Latest Thinking on Real-World Data
Bridging the Gap: Real-World Data Enhancing Clinical Trials
Randomized clinical trials (RCTs) have long been recognized as the gold standard for testing the safety and efficacy of pharmaceutical...
Read MoreFAQs about the FDA Guidance on the Use of Real-World Data and Real-World Evidence to Support Regulatory Decision-Making for Drug and Biological Products
Analyzing real-world data (RWD)1 to generate real-world evidence (RWE)2 is an emerging trend in the healthcare community. RWE is routinely...
Read MoreLeveraging Large Language Models like ChatGPT for Real-World Evidence Generation
Large Language Models (LLMs), including ChatGPT, have gained significant traction since late 2022, sparking debates about whether they’re mere hype...
Read MoreHealth Economics and Outcomes Research (HEOR): A Tool to Navigate the Biopharmaceutical Marathon
Congratulations! The decision to embark on the journey of founding a biopharmaceutical company is a courageous step indeed. Remember, as...
Read MoreThe Invisible Disease
“I got diagnosed in my early 20s” “I wanted to so badly say, ‘You guys have no idea. I’m in...
Read MoreOne drug, two Prices: Understanding the Role of Pharmacy Benefit Managers in US Drug Pricing
Humira, a top-selling drug with $200 billion in revenue over two decades, recently lost its patent monopoly. This paved the...
Read More